Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Clinical trial NCT04765098 · RECRUITING

Trial details

NCT number: NCT04765098
Sponsor: AHS Cancer Control Alberta
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2022-01-28
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.